Acoramidis
Acoramidis is currently under laboratory validation and pilot process optimization for TTR Stabilizer therapy.
Acoramidis is currently under laboratory validation and pilot process optimization for TTR Stabilizer therapy.
Resmetirom is currently under laboratory validation and pilot process optimization for Thyroid Hormone Receptor (THR) agonist therapy.
Vildagliptin operates through targeted therapeutic pathways for anti diabetic applications. Detailed pharmacological specifications are available upon technical request.
Fluconazole Form I operates through targeted therapeutic pathways for anti fungal applications. Detailed pharmacological specifications are available upon technical request.
